Glucagon-like peptide-1 (GLP-1) agonists and similar medications keep coming up in conversation. Their weight reduction benefits propelled them to fame, although they were first authorized for diabetes treatment. Both celebrities and regular people have used the medications, and more than half of Americans believe they are suitable options for those who are obese.
The Cleveland Clinic reports that a number of these drugs have the ability to reduce food intake by altering the way the brain and body respond to signals of hunger. A number of possibilities are discussed by Paunel Vukasinov, M.D., an internal medicine physician at Medical Offices of Manhattan, including how they function, who should take them, and other important information about the drugs. Read the article.
